[1]
Tabata Y. Tissue regeneration based on tissue engineering technology. Congenit Anom (Kyoto) 2004; 44: 111-124.
Google Scholar
[2]
Langer R, Vacanti JP. Tissue engineering. Science 1993; 260: 920-926.
Google Scholar
[3]
Urist MR, Strates BS. Bone morphogenetic protein. J Dent Res 1971; 50: 1392-1406.
DOI: 10.1177/00220345710500060601
Google Scholar
[4]
Schmitt JM, Hwang K, Winn SR, Hollinger JO. Bone morphogenetic proteins: an update on basic biology and clinical relevance. J Orthop Res 1999; 17: 269-278.
DOI: 10.1002/jor.1100170217
Google Scholar
[5]
Takahashi Y, Yamamoto M, Tabata Y. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate. Biomaterials 2005 Aug; 26(23): 4856-4865.
DOI: 10.1016/j.biomaterials.2005.01.012
Google Scholar
[6]
Na K, Kim SW, Sun BK, Woo DG, Yang HN, Chung HM, Park KH. Osteogenic differentiation of rabbit mesenchymal stem cells in thermo-reversible hydrogel constructs containing hydroxyapatite and bone morphogenic protein-2 (BMP-2). Biomaterials 2007 Jun; 28(16): 2631-2637.
DOI: 10.1016/j.biomaterials.2007.02.008
Google Scholar
[7]
Hayashi T, Kawai T, Ishikawa A, Kawai H, Nakano K, Takei Y, Kuroki K. Histological analysis of induced cartilage on the biodegradable or nonbiodegradable membranes from immature muscular tissue in vitro. J Biomed Mater Res A 2008; 86: 1048-1054.
DOI: 10.1002/jbm.a.31711
Google Scholar
[8]
Shi X, Garry DJ. Muscle stem cells in development, regeneration, and disease. Genes Dev 2006; 20: 1692-1708.
DOI: 10.1101/gad.1419406
Google Scholar
[9]
Ozkaynak E, Schnegelsberg PN, Jin DF, Clifford GM, Warren FD, Drier EA, Oppermann H. Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis. J Biol Chem 1992; 267: 25220-25227.
DOI: 10.1016/s0021-9258(19)74028-9
Google Scholar
[10]
Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci U S A 1990; 87: 9843-7.
DOI: 10.1073/pnas.87.24.9843
Google Scholar
[11]
Katagiri T, Yamaguchi A, Ikeda T, Yoshiki S, Wozney JM, Rosen V, Wang EA, Tanaka H, Omura S, Suda T. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 1990; 172: 295-299.
DOI: 10.1016/s0006-291x(05)80208-6
Google Scholar
[12]
Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T, Yoshiki S. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 1991; 113: 681-687.
DOI: 10.1083/jcb.113.3.681
Google Scholar
[13]
Okubo Y, Bessho K, Fujimura K, Iizuka T, Miyatake S. Expression of bone morphogenetic protein-2 via adenoviral vector in C2C12 myoblasts induces differentiation into the osteoblast lineage. Biochem Biophys Res Commun. 1999 Sep 7; 262(3): 739-743.
DOI: 10.1006/bbrc.1999.1281
Google Scholar
[14]
Hollister SJ. Porous scaffold design for tissue engineering. Nat Mater 2005; 4: 518-24.
Google Scholar